- This event has passed.
14th Annual BIO Asia International Conference – Corporate Presentation
March 14, 2017 @ 3:45 PM - 5:00 PM
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will present a corporate overview and participate on a panel at the BIO Asia International Conference. The conference is being held March 14-15, 2017, at the Grand Hyatt Tokyo, Japan.
The panel, titled “Fighting Neurodegeneration: New Models for Alzheimer’s Disease and Beyond”, will take place on Tuesday, March 14, from 2 p.m. to 2:55 p.m. Japan Standard Time and will feature an exploration of innovative therapeutic approaches to treating Alzheimer’s and other neurodegenerative diseases. Following the panel, Dr. Missling will make a corporate presentation beginning at 3:45 p.m. Japan Standard Time.